Psyence Extends GoldCoast Amalgamation Timeline and Lowers Cash Condition

Psyence Group ( (TSE:PSYG) ) has provided an update.

Psyence Group Inc., a biotechnology company focused on nature-derived psychedelic products for mental health, is pursuing a reverse takeover of private Ontario-based GoldCoast Resource Corp., whose environmentally focused offshore gold exploration in Ghana would become the core business of the resulting issuer. The shift would mark a strategic pivot from Psyence’s current psilocybin R&D activities toward mineral exploration, subject to shareholder and regulatory approvals.

The company has signed an amending agreement with GoldCoast and its subsidiary Psyence Therapeutics Corp. to extend key deadlines for their planned three-cornered amalgamation, pushing shareholder meetings to April 30, 2026 and the outside closing and termination dates to May 31, 2026. The parties also lowered Psyence’s minimum cash condition at closing from C$400,000 to C$250,000, while trading in Psyence’s shares remains halted as the Canadian Securities Exchange reviews the proposed change of business and the firms work to satisfy remaining conditions.

The most recent analyst rating on (TSE:PSYG) stock is a Sell with a C$0.11 price target. To see the full list of analyst forecasts on Psyence Group stock, see the TSE:PSYG Stock Forecast page.

Spark’s Take on TSE:PSYG Stock

According to Spark, TipRanks’ AI Analyst, TSE:PSYG is a Neutral.

The score is driven primarily by weak financial performance (no revenue, ongoing losses, and negative free cash flow), partially offset by an improved balance sheet (debt at 0 and equity positive). Technicals remain soft with the stock below key longer-term moving averages, and valuation is constrained by losses and no dividend. A recent RSU incentive program is a small positive but not a fundamental catalyst by itself.

To see Spark’s full report on TSE:PSYG stock, click here.

More about Psyence Group

Psyence Group Inc. is a life science biotechnology company developing nature-derived psychedelic products, particularly psilocybin-based therapies, for mental health and wellness applications. The company is in the process of a proposed reverse takeover of GoldCoast Resource Corp., after which the resulting issuer is expected to focus on GoldCoast’s offshore gold exploration business in Ghana, pending required approvals.

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$1.88M

Find detailed analytics on PSYG stock on TipRanks’ Stock Analysis page.